Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NewAmsterdam Pharma
Biotech
NewAmsterdam’s cholesterol ph. 3 hits, but disappoints investors
The biotech’s stock fell as investors chewed over findings such as a higher rate of discontinuations on a drug from a class with a troubled history.
Nick Paul Taylor
Nov 20, 2024 10:07am
NewAmsterdam drug cuts cholesterol, but by less than expected
Jul 29, 2024 8:00am
NewAmsterdam shares more data on lipid-lowering Amgen castoff
Apr 9, 2024 5:30am
Lonza lands new CEO—Chutes & Ladders
Apr 5, 2024 8:30am
3 Flagship biotechs make key exec hires—Chutes & Ladders
Aug 18, 2023 9:30am
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2
Jan 17, 2023 9:15am
